| 1 |
30806707 | Clinical efficacy of launched JAK inhibitors in rheumatoid arthritis. | 2019 Feb 1 |
1 |
| 2 |
28282491 | Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis. | 2017 Mar 10 |
2 |
| 3 |
28460083 | Estimated medical expenditure and risk of job loss among rheumatoid arthritis patients undergoing tofacitinib treatment: post hoc analyses of two randomized clinical trials. | 2017 Aug 1 |
2 |
| 4 |
27579831 | An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis: Modeling the Cost of Treatment Strategies in the United States. | 2016 Sep |
1 |
| 5 |
20233177 | Co-administration of the JAK inhibitor CP-690,550 and methotrexate is well tolerated in patients with rheumatoid arthritis without need for dose adjustment. | 2010 Feb |
1 |